{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T13:59:18Z","timestamp":1777211958337,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natural Science Basic Research Program of Shaanxi Province, China","award":["2019JM-364"],"award-info":[{"award-number":["2019JM-364"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objectives<\/jats:title>\n<jats:p>TORCH infections caused by <jats:italic>Toxoplasma gondii<\/jats:italic> (TOX), rubella virus (RV), cytomegalovirus (CMV) and herpes simplex virus 1,2 (HSV-1,2) are associated with congenital anomalies. The study aimed to analyze the characteristics of TORCH screening in reproductive age women.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A total of 18,104 women (2015\u20132017) from a teaching hospital in Xi\u2019an, China, were enrolled in the study. The characteristics of TORCH screening, i.e., the application of TORCH test, the seroprevalence, the impact of age, periods of gestation and woman with bad obstetric history (BOH) on the serological data were investigated.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>In the study, 319 women (1.76%) performed dynamic TORCH test. 51.66, 20.44 and 3.83% of the population did the test in the pre-gestation period, the first and third trimester, respectively. Quite a few pre-gestation women (29.74%) ignored screening of IgG antibodies. The overall IgG\/IgM seropositvity of TOX, RV, CMV, HSV-1 and HSV-2 was 4.35%\/0.35, 90%\/0.63, 96.79%\/0.97, 81.11%\/0.14 and 6.1%\/0.19%, respectively. The age-specific distributions and periods of gestation had no significant effect on the seroprevalence of TORCH agents, <jats:italic>p<\/jats:italic>&gt;0.05. However, BOH was significantly associated with higher seropositvity of IgM (RV, CMV, HSV-1 and HSV-2) and IgG (CMV and HSV-1) antibodies, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>In Xi\u2019an region, more attentions should be paid to TOX, CMV, HSV-2 and the women with BOH for TORCH screening. Meanwhile, a greater emphasis needs to be placed on TORCH test used inappropriately in China.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12884-019-2642-7","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T17:03:31Z","timestamp":1575911011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["TORCH screening used appropriately in China?\u2500three years results from a teaching hospital in northwest China"],"prefix":"10.1186","volume":"19","author":[{"given":"Lin-Chuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Xiong","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"issue":"9","key":"2642_CR1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/14787210.2016.1215913","volume":"14","author":"L Madrid","year":"2016","unstructured":"Madrid L, Varo R, Sitoe A, Bassat Q. Congenital and perinatally-acquired infections in resource-constrained settings. Expert Rev Anti-Infect Ther. 2016;14(9):845\u201361.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"4","key":"2642_CR2","first-page":"253","volume":"2","author":"BJ Stegmann","year":"2002","unstructured":"Stegmann BJ, Carey JC, TORCH Infections. Toxoplasmosis, other (syphilis, varicella-zoster, parvovirus B19), rubella, Cytomegalovirus (CMV), and herpes infections. Curr Womens Health Rep. 2002;2(4):253\u20138.","journal-title":"Curr Womens Health Rep"},{"issue":"1","key":"2642_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clp.2014.11.001","volume":"42","author":"N Neu","year":"2015","unstructured":"Neu N, Duchon J, Zachariah P. TORCH infections. Clin Perinatol. 2015;42(1):77\u2013103.","journal-title":"Clin Perinatol"},{"issue":"1","key":"2642_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/j.nainr.2004.01.001","volume":"4","author":"SG Boyer","year":"2004","unstructured":"Boyer SG, Boyer KM. Update on TORCH infections in the newborn infant. Newborn Infant Nurs Rev. 2004;4(1):70\u201380.","journal-title":"Newborn Infant Nurs Rev"},{"issue":"3","key":"2642_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/archdischild-2012-303327","volume":"98","author":"EPD Jong","year":"2013","unstructured":"Jong EPD, Vossen ACTM, Walther FJ, Lopriore E. How to use... neonatal TORCH testing. Arch Dis Child Educ Pract Edit. 2013;98(3):93\u20138.","journal-title":"Arch Dis Child Educ Pract Edit"},{"issue":"12","key":"2642_CR6","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3855\/jidc.1533","volume":"5","author":"J Kishore","year":"2011","unstructured":"Kishore J, Misra R, Paisal A, Pradeep Y. Adverse reproductive outcome induced by parvovirus B19 and TORCH infections in women with high-risk pregnancy. J Infect Dev Ctries. 2011;5(12):868\u201373.","journal-title":"J Infect Dev Ctries"},{"issue":"6","key":"2642_CR7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/eurpub\/ckm034","volume":"17","author":"A Dominguez","year":"2007","unstructured":"Dominguez A, Plans P, Espunes J, et al. Rubella immune status of indigenous and immigrant pregnant women in Catalonia, Spain. Eur J Public Health. 2007;17(6):560\u20134.","journal-title":"Eur J Public Health"},{"issue":"12","key":"2642_CR8","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/S1701-2163(16)30079-2","volume":"37","author":"VYMH Poliquin","year":"2015","unstructured":"Poliquin VYMH, Murphy KE, et al. Antepartum screening for maternal infection and immune status: is it time to broaden our routine? J Obstet Gynaecol Can. 2015;37(12):1118\u201321.","journal-title":"J Obstet Gynaecol Can"},{"issue":"2","key":"2642_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.actatropica.2011.10.018","volume":"121","author":"YTC Carlier","year":"2012","unstructured":"Carlier YTC, Deloron P, et al. Congenital parasitic infections: a review. Acta Trop. 2012;121(2):55\u201370.","journal-title":"Acta Trop"},{"issue":"4","key":"2642_CR10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1128\/CMR.15.4.680-715.2002","volume":"15","author":"MG Revello","year":"2002","unstructured":"Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev. 2002;15(4):680\u2013715.","journal-title":"Clin Microbiol Rev"},{"key":"2642_CR11","doi-asserted-by":"crossref","unstructured":"Ursu RG, Costin D, Iancu LS, et al. The clinical utility of TORCH testing of pregnant women from northeastern Romanian population: application of electrochemiluminiscence assay. E-Health Bioeng Conf. 2015. p. 1\u20134.","DOI":"10.1109\/EHB.2015.7391504"},{"issue":"10054","key":"2642_CR12","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/S0140-6736(16)31405-2","volume":"388","author":"Yi Zeng","year":"2016","unstructured":"Zeng Y, Hesketh T. The effects of China's universal two-child policy. Lancet. 2016;388(10054):1930\u20138.","journal-title":"The Lancet"},{"issue":"3","key":"2642_CR13","first-page":"5158","volume":"6","author":"N Saxena","year":"2015","unstructured":"Saxena N, Lal M, Mittal G, Priya P. Is screening of TORCH worthwhile in women with bad obstetric history: an observational study from Himalayan hospital? Int J Biol Med Res. 2015;6(3):5158\u201361.","journal-title":"Int J Biol Med Res"},{"issue":"2","key":"2642_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/cga.12138","volume":"56","author":"S Rasti","year":"2016","unstructured":"Rasti S, Ghasemi FS, Abdoli A, Piroozmand A, Mousavi SGA, Fakhrie-Kashan Z. ToRCH \u201cco-infections\u201d are associated with increased risk of abortion in pregnant women. Congenital Anomalies. 2016;56(2):73\u20138.","journal-title":"Congenital Anomalies"},{"issue":"1\u20132","key":"2642_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cca.2009.03.027","volume":"403","author":"Z Li","year":"2009","unstructured":"Li Z, Yang C, Liu P, et al. Prevalence of serum antibodies to TORCH among women before pregnancy or in the early period of pregnancy in Beijing. Clinica Chimica Acta. 2009;403(1\u20132):212\u20135.","journal-title":"Clinica Chimica Acta"},{"issue":"3","key":"2642_CR16","first-page":"203","volume":"2","author":"O Numan","year":"2015","unstructured":"Numan O, Vural F, Aka N, Alpay M, Coskun AD. TORCH seroprevalence among patients attending obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to association of Istanbul northern Anatolia public hospitals. North Clin Istanb. 2015;2(3):203\u20139.","journal-title":"North Clin Istanb"},{"issue":"5","key":"2642_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s13224-014-0615-3","volume":"65","author":"KR Prasoona","year":"2015","unstructured":"Prasoona KR, Srinadh B, Sunitha T, Sujatha M, Deepika ML, Vijaya LB, Ramaiah A, Jyothy A. Seroprevalence and influence of Torch Infections in high risk pregnant women: a large study from South India. J Obstet Gynaecol India. 2015;65(5):301\u20139.","journal-title":"J Obstet Gynaecol India"},{"issue":"4","key":"2642_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1863-2378.2008.01177.x","volume":"56","author":"V Messier","year":"2009","unstructured":"Messier V, L\u00e9vesque B, Proulx JF, Rochette L, Libman MD, Ward BJ, Serhir B, Couillard M, Ogden NH, Dewailly E. Seroprevalence of toxoplasma gondii among Nunavik Inuit (Canada). Zoonoses Public Health. 2009;56(4):188\u201397.","journal-title":"Zoonoses Public Health"},{"issue":"7","key":"2642_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s100960000317","volume":"19","author":"DY Miendje","year":"2000","unstructured":"Miendje DY, Goubau P, Bod\u00e9us M. False-positive IgM antibody tests for cytomegalovirus in patients with acute Epstein-Barr virus infection. Eur J Clin Microbiol Infect Dis. 2000;19(7):557\u201360.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2642_CR20","unstructured":"De SC, Tabacco S, Rizzo F, Perrone G, Garufi C, Botta A, Salvi S, Benedetti PP, Lanzone A. Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women. Lupus. 2017;(4) 096120331774156."},{"issue":"2","key":"2642_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3109\/14767058.2016.1169521","volume":"30","author":"OGL Picone","year":"2017","unstructured":"Picone OGL, Senat M, et al. Cytomegalovirus non-primary infection during pregnancy. Can serology help with diagnosis? J Matern Fetal Neonatal Med. 2017;30(2):224\u20137.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2642_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12884-019-2360-1","volume":"19","author":"T Yuka","year":"2019","unstructured":"Yuka T, Shigeru Y, Yoichiro Y, et al. Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection. BMC Pregnancy Childbirth. 2019;19:205.","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2642-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-019-2642-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2642-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:36:45Z","timestamp":1607387805000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-019-2642-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2642"],"URL":"https:\/\/doi.org\/10.1186\/s12884-019-2642-7","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"8 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Due to the retrospective nature and all patient\u2019s information was kept confidential, the study was deemed exempt from review and approved to be not require informed consent by the Institutional Review Board of the First Affiliated Hospital of Xi\u2019an Jiaotong University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"484"}}